fig5
Figure 5. Novel application nanotechnology in pulmonary embolism. (A) specially designed lipid nanoparticle named tP-NP-rtPA/ZL006e. (B) tP-NP-rtPA/ZL006e was injected intravenously. It is directed to the thrombus for the thrombin-triggered release of rtPA. (C) Tat-mediated transcytosis helps in the transfer of nanocarriers into the brain.
